Condition: Osteoarthritis, Hip · Cardiovascular Diseases · Bone Cement Implantation Syndrome · Sponsor: University of Tartu
Total joint arthroplasty is one of the best treatment options for end-stage osteoarthritis. Cemented hip arthroplasty is mainly indicated for elderly patients with poor bone quality and multiple comorbidities. Bone cement implantation syndrome is associated with cemented hip arthroplasty and it has been shown to increase cardiovascular and renal complication and brain damage postoperatively. The aim of this project is to elucidate whether remote-ischemic preconditioning (RIPC) has multi-organ protective effect in cemented hip arthroplasty patients.
This description comes directly from the study's public registry record.
Kaspar Tootsi, PhD · +372 7318282 · kaspar.tootsi@kliinikum.ee
Kaarel Ernits, MD · kaarel.ernits@kliinikum.ee
Always discuss trial participation with your own doctor first.
| University of Tartu | Tartu, Tartu, Estonia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06323018